Abiopharma

New Form ARS - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085125 Size: 796 KB

New Form S-3/A - Vivos Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026733 Size: 415 KB

Kooij Louise Frederika 🔴 sold 18.1K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $25.09 Transaction Date: Sep 03, 2025 | Filing ID: 113276

New Form DEF 14A - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085119 Size: 4 MB

New Form 8-K - FIBROGEN INC Filed: 2025-09-05 AccNo: 0000921299-25-000007 Size: 525 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

New Form 424B3 - Tivic Health Systems, Inc. Filed: 2025-09-05 AccNo: 0001683168-25-006729 Size: 222 KB

AGF Management Limited to Release Third Quarter 2025 Financial Results on September 24, 2025

Le 24 septembre 2025, La Société de Gestion AGF Limitée annoncera ses résultats financiers pour le troisième trimestre de 2025

AGF déclare le total de son actif géré et de ses actifs donnant droit à des commissions pour août 2025

AGF Reports August 2025 Assets Under Management and Fee-Earning Assets

Ramaswamy Vivek 🔴 sold 1.8M shares of Roivant Sciences Ltd. (ROIV) at $12.96 ($22.5M) Transaction Date: Sep 03, 2025 | Filing ID: 000007

New Form SCHEDULE 13D/A - STRATA Skin Sciences, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085116 Size: 13 KB

New Form 3 - Sintx Technologies, Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012751 Size: 5 KB

New Form SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC Filed: 2025-09-05 AccNo: 0001041062-25-000177 Size: 6 KB

Elsbernd Brian 🟡 adjusted position in 50.0K shares (2 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) at $20.08 ($1.2M) Transaction Date: Sep 03, 2025 | Filing ID: 000318